Scan to download
Coin: 8b6eTuyAkHhCiQRwmpS1tdPCcUUELACJsnzwhwnapump
replies: 7
Quince Therapeutics Inc (QNCX): Quince Therapeutics is a clinical-stage biotechnology company that specializes in developing treatments for rare and debilitating diseases by leveraging a patient's own biology. The company's core technology and lead programs include: AIDE Technology Platform: Their proprietary "Autologous Intracellular Drug Encapsulation" system uses a specialized device to encapsulate drugs directly into a patient’s own red blood cells. This method is designed to prolong the drug's half-life and reduce toxic side effects by controlling its release over several weeks. eDSP (EryDex): The lead product candidate, currently in Phase 3 clinical trials, targets Ataxia-Telangiectasia (A-T), a rare pediatric neurodegenerative disorder with no current approved treatment. It delivers a corticosteroid (dexamethasone) in a way that minimizes the typical long-term side effects like adrenal suppression. Bone-Targeting Platform: They are also developing precision therapeutics designed to deliver molecules directly to the site of bone fractures and diseases to promote faster healing. The company was formerly known as Cortexyme and officially rebranded to Quince Therapeutics in August 2022.
Insults, Unwanted Sexual Content & Graphic Objectification, Unwanted NSFW & Graphic Content, Violent Event Denial, Targeted Harassment and Inciting Harassment
Child sexual exploitation, grooming, physical child abuse, underage user
Encouraging, promoting, providing instructions or sharing strategies for self-harm.
Graphic Content, Gratuitous Gore, Adult Nudity & Sexual Behavior, Violent Sexual Conduct, Bestiality & Necrophilia, Media depicting a deceased individual.
Please explain why should be removed.
